Iovate supplement patent ruled invalid
This article was originally published in The Tan Sheet
Supplements made by Bio-Engineered Supplements & Nutrition Inc. did not infringe a patent on a certain formulation of a ketoacid and an amino acid to enhance muscle performance, a federal appellate court says. Iovate Health Sciences appealed a summary judgment order by a U.S. district court in Texas, which had declared Iovate's patent invalid as anticipated by prior advertising. In a Nov. 19 1decision, the U.S. Court of Appeals for the Federal Circuit affirmed the lower court's decision, finding Iovate's patent on the ketoacid/amino acid supplement anticipated by earlier ads for TwinLab Mass Fuel and Weider's VICTORY Professional Protein products
You may also be interested in...
The entry of India’s state-owned Indian Immunologicals and partner Griffith University in the COVID-19 vaccine race could potentially disrupt pricing dynamics. The alliance is developing a live-attenuated, single dose vaccine, which it hopes will be ready for launch in 18-24 months.
Shortly after wrapping up a Phase III trial for its proposed generic Advair Diskus product in the US, Cipla has won FDA approval for the first generic Proventil HFA product, as it continues to build up steam in the US respiratory market.
The UK's MHRA is looking for manufacturers to submit COVID-19 self-tests that meet minimum and desired criteria for evaluation, after finding its recently purchased 3.5m self-tests failed to meet these standards. Criteria include no requirement for testing knowledge or training or assistance from a healthcare professional in administering or interpreting the results of the test, as well as a 95% accuracy level.